{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:59:02Z","timestamp":1759496342634},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.yrtph.2009.12.007","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T04:08:59Z","timestamp":1262664539000},"page":"166-173","source":"Crossref","is-referenced-by-count":3,"title":["An alternative interpretation of, \u201cA lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats\u201d"],"prefix":"10.1016","volume":"56","author":[{"given":"Ernest E.","family":"McConnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Lippes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger G.","family":"Growe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Fail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael I.","family":"Luster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Errol","family":"Zeiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2009.12.007_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01849751","article-title":"Clinical evaluation of quinacrine pellets for chemical female sterilization","volume":"8","author":"Agoestina","year":"1992","journal-title":"Adv. Contracept."},{"key":"10.1016\/j.yrtph.2009.12.007_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0015-0282(16)44784-9","article-title":"Quinacrine-induced pathologic changes in the fallopian tube","volume":"33","author":"Bhatt","year":"1980","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.yrtph.2009.12.007_bib3","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0020-7292(03)90103-2","article-title":"Marie Stopes Society, Pakistan: 1000 cases of quinacrine sterilization (QS)","volume":"83","author":"Bilgrami","year":"2003","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.yrtph.2009.12.007_bib4","doi-asserted-by":"crossref","unstructured":"Bucher, J.R., Portter, C.J., Goodman, J.I., Faustman E.M., Lucier, G.W., 1996. Workshop Overview. National Toxicology Program Studies: principles of dose selection and applications to mechanistic based risk assessment, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.","DOI":"10.1093\/toxsci\/31.1.1"},{"key":"10.1016\/j.yrtph.2009.12.007_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1749-6632.2002.tb04934.x","article-title":"The national toxicology program rodent bioassay: designs, interpretations, and scientific contributions","volume":"982","author":"Bucher","year":"2002","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.yrtph.2009.12.007_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10915810600605773","article-title":"A one-year neonatal mouse carcinogenesis study of quinacrine dihydrochloride","volume":"25","author":"Cancel","year":"2006","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2009.12.007_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yrtph.2009.07.008","article-title":"A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats","volume":"56","author":"Cancel","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.12.007_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01850712","article-title":"Histopathologic changes in the cornual portion of the fallopian tube following a single transcervical insertion of quinacrine hydrochloride pellets","volume":"7","author":"El-Kady","year":"1991","journal-title":"Adv. Contracept."},{"issue":"2","key":"10.1016\/j.yrtph.2009.12.007_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0015-0282(99)00537-3","article-title":"Comparative effects of quinacrine and erythromycin in adult female rats: a nonsurgical sterilization study","volume":"73","author":"Fail","year":"2000","journal-title":"Fertil. Steril."},{"issue":"Suppl 2","key":"10.1016\/j.yrtph.2009.12.007_bib10","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0020-7292(03)90091-9","article-title":"Quinacrine female nonsurgical sterilization (QS): endometrial assessment by vaginal ultrasonography in 128 women","volume":"83","author":"Ferreira","year":"2003","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.yrtph.2009.12.007_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/rtph.1997.1125","article-title":"Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay","volume":"26","author":"Flammang","year":"1997","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.yrtph.2009.12.007_bib12","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0020-7292(03)90094-4","article-title":"The acceptability, efficacy and safety of quinacrine non-surgical sterilization (QS), tubectomy and vasectomy in 5 provinces in the Red River Delta, Vietnam: a follow-up of 15, 190 cases","volume":"83","author":"Hieu","year":"2003","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.yrtph.2009.12.007_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0140-6736(93)92302-A","article-title":"31, 781 cases of nonsurgical female sterilization with quinacrine pellets in Vietnam","volume":"342","author":"Hieu","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2009.12.007_bib14","unstructured":"International Conference on Harmonisation, 2008. In: European Medicines Agency, Note for Guidance on dose selection for carcinogenicity studies of pharmaceuticals, ICH Expert Working Group, Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. 7 Westferry Circus, Canary Wharf, London, E14 4HB, United Kingdom."},{"key":"10.1016\/j.yrtph.2009.12.007_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0897.2006.00389.x","article-title":"Human oviductal stromal fibroblasts, but not oviductal epithelial cells, express toll-like receptor 4: the site-specific mucosal immunity of the human fallopian tube against bacterial infection","volume":"56","author":"Itoh","year":"2006","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.yrtph.2009.12.007_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01849629","article-title":"100, 000 quinacrine sterilizations","volume":"12","author":"Kessel","year":"1997","journal-title":"Adv. Contracept."},{"key":"10.1016\/j.yrtph.2009.12.007_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","article-title":"Inflammation: gearing the journey to cancer","volume":"659","author":"Kundu","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2009.12.007_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0010-7824(96)00174-6","article-title":"Phase I prehysterectomy studies of the transcervical administration of quinacrine pellets","volume":"54","author":"Laufe","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.yrtph.2009.12.007_bib19","series-title":"Oviduct, Uterus and Vagina, in Pathology of the Fischer Rat: Reference and Atlas","author":"Leininger","year":"1990"},{"key":"10.1016\/j.yrtph.2009.12.007_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0010-7824(72)90021-2","article-title":"The collection and analysis of human fallopian tubal fluid","volume":"5","author":"Lippes","year":"1972","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.yrtph.2009.12.007_bib21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0015-0282(02)03089-3","article-title":"Editorial. Quinacrine sterilization: the imperative need for American clinical trials","volume":"77","author":"Lippes","year":"2002","journal-title":"Fertil. Steril."},{"issue":"Suppl 2","key":"10.1016\/j.yrtph.2009.12.007_bib22","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0020-7292(03)90089-0","article-title":"An FDA phase I clinical trial of quinacrine sterilization (QS)","volume":"83","author":"Lippes","year":"2003","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"Suppl 2","key":"10.1016\/j.yrtph.2009.12.007_bib23","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/S0020-7292(03)90090-7","article-title":"A comparison of quinacrine sterilization (QS) and surgical sterilization (TL) in 600 women in Guizhou Province, China","volume":"83","author":"Lu","year":"2003","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.yrtph.2009.12.007_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00204-008-0304-z","article-title":"Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis","volume":"82","author":"Mat\u00e9s","year":"2008","journal-title":"Arch. Toxicol."},{"issue":"Suppl.","key":"10.1016\/j.yrtph.2009.12.007_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/019262301753178537","article-title":"Neonatal mouse model: review of methods and results","volume":"29","author":"McClain","year":"2001","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2009.12.007_bib26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3109\/10915818909018071","article-title":"The maximum tolerated dose: the debate","volume":"6","author":"McConnell","year":"1989","journal-title":"J. Am. Coll. Toxicol."},{"key":"10.1016\/j.yrtph.2009.12.007_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01849300","article-title":"Clinico-pathological study of fallopian tubes after transcervical insertion of quinacrine hydrochloride pellets","volume":"2","author":"Merchant","year":"1986","journal-title":"Adv. Contracept."},{"key":"10.1016\/j.yrtph.2009.12.007_bib28","first-page":"47","article-title":"Clinicopathologic study of fallopian tube closure after single transcervical insertion of quinacrine pellets","volume":"40","author":"Merchant","year":"1995","journal-title":"Int. J. Fertil."},{"key":"10.1016\/j.yrtph.2009.12.007_bib29","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1128\/IAI.72.10.5799-5806.2004","article-title":"Differential expression of toll-like receptors 2 and 4 in tissues of the human female reproductive tract","volume":"72","author":"Pioli","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.yrtph.2009.12.007_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-0378(02)00019-0","article-title":"The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells","volume":"57","author":"Quayle","year":"2002","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.yrtph.2009.12.007_bib31","unstructured":"Randic, L., 2000. Results of Phase II QS trials in Croatia. Presentation to Planned Parenthood Federation of America\u2019s National Medical Committee\u2019s Ad Hoc Committee on Quinacrine Sterilization, July 18, 1999. In: Quinacrine Newsletter 2000, International Services Assistance Fund, Research Triangle Park, NC."},{"issue":"3","key":"10.1016\/j.yrtph.2009.12.007_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006757914435","article-title":"Quinacrine sterilization: experience among women at high risk for surgery","volume":"15","author":"Sarin","year":"1999","journal-title":"Adv. Contracept."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2009.12.007_bib33","first-page":"S164","article-title":"Histologic changes in the fallopian tubes after lower dose of transcervical quinacrine insertion","volume":"70","author":"Sarin","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.yrtph.2009.12.007_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.contraception.2008.02.011","article-title":"Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam","volume":"78","author":"Sokal","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.yrtph.2009.12.007_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.contraception.2009.07.006","article-title":"Cancer risk after sterilization with transcervical quinacrine: updated findings from a Chilean cohort","volume":"81","author":"Sokal","year":"2010","journal-title":"Contraception."},{"key":"10.1016\/j.yrtph.2009.12.007_bib36","unstructured":"Sokal, D.C., Vach, T.H., Nanda, K., McCann, M.F., Weiner, D.H., Drobnes, C., Rochanawutanon, M., Duc, N.B., Loan, N.D., in press. Quinacrine sterilization and gynecologic cancers: a case-control study in northern Vietnam. Epidemiology."},{"issue":"Suppl. 2","key":"10.1016\/j.yrtph.2009.12.007_bib37","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0020-7292(03)90096-8","article-title":"Quinacrine sterilization (QS) in Iran and the use of HSG as a measure of success","volume":"83","author":"Soroodi-Moghaddam","year":"2003","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.yrtph.2009.12.007_bib38","unstructured":"United States Environmental Protection Agency. Health Effects Test Guidelines: OPPTS 870.4200 Carcinogenicity. Prevention, Pesticides and Toxic Substances (7101), EPA 712-C-98-211, August 1998."},{"key":"10.1016\/j.yrtph.2009.12.007_bib39","unstructured":"United States Food and Drug Administration and International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2008. Guidance for Industry: S1C(R2) Dose Selection for Carcinogenicity Studies. Revision 1, September 2008. U.S. Department of Health and Human Services Center for Drug Evaluation and Research, pp. 2\u20135."},{"key":"10.1016\/j.yrtph.2009.12.007_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/j.1879-3479.1980.tb00496.x","article-title":"Quinacrine hydrochloride pellets: preliminary data on a nonsurgical method of female sterilization","volume":"18","author":"Zipper","year":"1980","journal-title":"Int. J. Gynecol. Obstet."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230009002463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230009002463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T18:41:26Z","timestamp":1558723286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230009002463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0273230009002463"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2009.12.007","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}